Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
09/2001
09/04/2001USH1992 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their pharmaceutical uses
09/04/2001US6284919 Liquid phase carbonylation of ethylene using carbon monoxide in the presence of palladium with phosphine
09/04/2001US6284914 Highly water-soluble metalloproteinase inhibitors
09/04/2001US6284910 Farnesyl pyrophosphate analogs
09/04/2001US6284909 Preparations of thiophosphites and thiophosphonates
09/04/2001US6284899 Useful for the detection of triggering agents including enzymes.
09/04/2001US6284869 Prepregs and electrolaminates
09/04/2001US6284854 Polymeric surface coatings
09/04/2001US6284813 Alkylphenylbisacylphosphine oxides and photoinitiator mixtures
09/04/2001US6284748 Antidiabetic agent
09/04/2001US6284267 Amphiphilic materials and liposome formulations thereof
09/04/2001CA2073126C Preparation of alkylphosphocholines
08/2001
08/30/2001WO2001062766A1 Method for preparing sterically hindered phosphoramidates
08/30/2001WO2001062718A1 Benzamide derivative and use thereof
08/30/2001WO2001062375A1 Neutralization of phosphate esters, compositions based upon and methods using same
08/30/2001US20010018537 Isocyanates modified to give them a surfactant property, composition containing them and coating resulting therefrom
08/30/2001US20010018536 Catalytic oxidation
08/30/2001US20010018534 Aluminum phosphinimine complexes
08/30/2001US20010018525 Modulating blood glucose concentration
08/30/2001US20010018514 Nucleic acid labeling compounds
08/30/2001US20010018510 Synthesis of oligonucleotides
08/30/2001US20010018461 Ethylenically unsaturated amine salts of sulfonic, phosphoric, and carboxylic acids
08/30/2001US20010018440 L-beta-dioxolane uridine analogs and methods for treating and preventing virus infections
08/30/2001US20010018430 Anticancer agents, psoriasis, restenosis, atherosclerosis
08/30/2001US20010018429 Neurotransmitter
08/30/2001US20010018425 New compounds for the treatment of cancer
08/30/2001US20010018179 Porous adsorbent particles immobilized on matrix
08/30/2001CA2400314A1 Neutralization of phosphate esters, compositions based upon and methods using same
08/30/2001CA2368447A1 Small molecule modulators of g protein-coupled receptor six
08/29/2001EP1127888A1 Lithium fluoralkylphosphates and their use as electrolyte salts
08/29/2001EP1127872A1 Tamiflu via Diels-Alder
08/29/2001EP1127041A1 Process for manufacturing alkanes
08/29/2001EP1127037A1 Resolution method for a racemic mixture of aldehydes
08/29/2001EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
08/29/2001EP0968168B1 Aromatic tetracyclic compounds of the retinoid type, method for preparing and use
08/29/2001EP0752998B1 Thionation process using elemental phosphorus and sulfur
08/29/2001EP0736030B1 Tetrahydrofuran antifungals
08/29/2001CN1310721A Medicine nitrate salts
08/29/2001CN1310720A Organophosphorus compounds for dental polymerizable compositions
08/29/2001CN1310170A Process for producing 4,5-diamino shikimic acid derivative
08/29/2001CN1070195C Process for producing organic phosphorus ester compound
08/29/2001CN1070194C Vanadium base catalyst and its use
08/29/2001CN1070180C Pharmaceutical formulations containing polythiourea and its using method
08/29/2001CN1070175C Process for producing 2,6-di-substituted ester benzenesulfonate
08/28/2001US6281390 Chiral diphenyldiphosphines and d-8 metal complexes thereof
08/28/2001US6281381 Crystal structure
08/28/2001US6281306 Spray drying
08/28/2001CA2017252C Retroviral protease inhibiting compounds
08/25/2001CA2337926A1 Lithium fluoroalkylphosphates and their use as electrolyte salts
08/23/2001WO2001060830A1 Method for producing n-(phosphonomethyl)glycine
08/23/2001WO2001060829A1 Phosphororganic compounds and the use thereof
08/23/2001WO2001060820A2 Matrix metalloproteinase inhibitors and uses thereof
08/23/2001WO2001060416A2 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents
08/23/2001US20010016662 Phosphonooxyalkyltriazole or pyrazole inorganic or organic quaternary salt compounds are useful for treatment of serious systemic fungal infections
08/23/2001US20010016652 Providing a purine or pyrimidine base containing nucleoside with acid labile hydroxyl protecting group and a base labile hydroxy protecting group substitutions, deblocking hydroxy group, treating with phosphonate compound, condensing agent
08/23/2001US20010016346 Pedtidyl-prolyl cis-trans isomerase inhibitors and uses therefore
08/23/2001US20010016343 Derivatized biotin compounds and methods
08/23/2001DE10007702A1 Verfahren zur Herstellung von N-(Phosphonomethyl)glycin Process for the preparation of N- (phosphonomethyl) glycine
08/23/2001DE10006870A1 Aluminium-phosphinat-Gemische Aluminum phosphinate mixtures
08/23/2001DE10006592A1 Latente Kombinationsverbindungen und latente Ammoniumsalze aus Epoxidharzhärter und Flammschutzmittel sowie daraus hergestellte Epoxidharz-Systeme und -Produkte Deferred combination compounds and latent ammonium salts of epoxy resin curing and flame retardants, and from epoxy resin systems and products produced
08/23/2001CA2399947A1 Phosphororganic compounds and the use thereof
08/23/2001CA2395841A1 Matrix metalloproteinase inhibitors and uses thereof
08/23/2001CA2395038A1 Matrix metalloproteinase inhibitors
08/22/2001EP1125960A2 A latent combination compound and a latent ammonium salt from an epoxy resin curing agent and a flame retardant, epoxy resin systems or -products made therefrom
08/22/2001EP1125942A1 Derivatives of 6-amino or 6-hydrazinosulfonyl-3-quinolyl phosphonic acids, process for their preparation and pharmaceutical compositions containing them
08/22/2001EP1125941A1 Derivatives of 6-sulfamoyl-3-quinolyl phosphonic acids, process for their preparation and pharmaceutical compositions containing them
08/22/2001EP1125940A1 Derivatives of aryl or heteroaryl quinolinylphosphonic acids, process for their preparation and pharmaceutical compositions containing them
08/22/2001EP1124838A2 Nucleic acid labeling compounds
08/22/2001EP1124833A1 Diphosphines
08/22/2001EP1124832A1 Oxime derivatives and the use thereof as latent acids
08/22/2001EP0923521B1 Olefin hydroformylation process in a two-phase system
08/22/2001EP0811010B1 Metallocene complexes with cationic bridges
08/22/2001CN1309660A Phosphinous and phosphonic acid derivs. used as medicaments
08/22/2001CN1309659A Phosphorous organic compounds and their use
08/22/2001CN1309638A N-substd. naphthalene carboxamides as neurokinin-receptor antagonists
08/22/2001CN1309128A Process for preparing 1-hydroxyl-1-carboxylfatty phosphonic acid
08/22/2001CN1069904C Water stable L-ascorbic acid deriv. and its preparation method, and beauty composition contg. same for making face white skinned
08/21/2001US6278024 As catalysts for assymetric synthesis
08/21/2001US6278017 Continuous process for the preparation of N-(phosphonomethyl)iminodiacetic acid
08/21/2001US6278012 Process for preparing phosphinate esters
08/21/2001US6277988 Solvent-free method for preparing sterically hindered phosphoramidates
08/21/2001US6277885 Inhibitors of tumor necrosis factor-alpha converting enzyme
08/21/2001US6277833 3-hydroxy-3-methyl-glutaryl coenzyme a (hgm--coa) reductase inhibitors which retard cholesterol biosynthesis
08/21/2001US6277570 Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
08/21/2001CA2198588C Formation of a metalorganic compound for growing epitaxial semiconductor layers
08/21/2001CA2030792C Perfluorovinyl compounds
08/18/2001CA2337786A1 New derivatives of phosphonic 6-sulfamoyl-3-quinolyl acids, the process for the preparation thereof and the pharmaceutical compounds containing them
08/18/2001CA2337785A1 New derivatives of phosphonic 6-amino or 6-hydrazinosulfonyl-3-quinolinyl acids, the process for the preparation thereof and the pharmaceutical compounds containing them
08/18/2001CA2337301A1 New quinolinyl phosphonic aryl or heteroaryl acid derivatives, their preparation process and the pharmaceutical compositions containing same
08/18/2001CA2336740A1 Raney copper
08/16/2001WO2001059087A2 Compositions for transfecting nucleic acids and their use
08/16/2001WO2001059001A1 Use of bridged halogenated aryl phosphates as flameproofing agents
08/16/2001WO2001058966A1 Polymerisation catalyst
08/16/2001WO2001058911A1 N-(phosphono-alkyl)glycines and n-(phosphono-aryl)glycines, their application as herbicides and their production
08/16/2001WO2001058853A1 Dehydroamino acids
08/16/2001WO2001058843A1 Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups
08/16/2001WO2001058808A1 Method of preparation for silica (sio2) from rice bran
08/16/2001WO2001058589A1 PHOSPHOR, ARSENIC AND ANTIMONY COMPOUNDS BASED UPON DIARYL-ANELLATED BICYCLO`2.2.N! PARENT SUBSTANCES AND CATALYSTS CONTAINING SAME
08/16/2001WO2001009385A3 Attachment of oligonucleotides to solid supports through schiff base type linkages for capture and detection of nucleic acids
08/16/2001WO2001008492A8 Process for making a downstream processable ammonium glyphosate paste